《大行報告》高盛微降港交所(00388.HK)目標價至598元 重申「買入」
高盛發表研究報告指出,下調港交所(00388.HK)2021至25年每股盈測0-3%,目標價由601元下調至598元,重申「買入」評級,認爲其推出MSCI中國A50互聯互通指數期貨合約,有助分散收益來源,擺脫對現貨市場的嚴重依賴,其業務將繼續以股票爲中心,更活躍的衍生品市場可能會降低交易所的整體收益波動。
該行預期,港交所的現金股票收入將佔2021年收入的48%,與2007至2011年的平均水平相同。而隨着A50互聯互通期貨的貢獻,預測至2025年,衍生品(不包括LME)交易的複合年增長率約爲16%,較現金股票的12%爲高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.